Low enantioselectivities of human deoxycytidine kinase and human deoxyguanosine kinase with respect to 2′-deoxyadenosine, 2′-deoxyguanosine and their analogs

被引:11
作者
Gaubert, G
Gosselin, G
Boudou, V
Imbach, JL
Eriksson, S
Maury, G
机构
[1] Univ Montpellier 2, Chim Bioorgan Lab, CNRS, UMR 5625, F-34095 Montpellier 5, France
[2] Swedish Univ Agr Sci, Ctr Biomed, Dept Vet Med Chem, S-75123 Uppsala, Sweden
关键词
deoxycytidine kinase; deoxyguanosine kinase; enantioselectivity; substrate properties; L-nucleoside analogs;
D O I
10.1016/S0300-9084(99)00331-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The antiviral activity of L-nucleoside analogs depends in part on the enantioselectivity of nucleoside kinases which catalyse their monophosphorylation. The substrate properties of human recombinant deoxycytidine kinase (dCK) and human recombinant deoxyguanosine kinase (dGK) with respect to L-adenosine and L-guanosine analogs, in the presence of saturating amounts of ATP and relatively high concentrations of substrates, demonstrated a marked lack of enantioselectivity of both these enzymes. Human dCK catalysed the phosphorylation of D- and L-enantiomers of beta-dA, beta-araA, and beta-dG with enantioselectivities favoring the unnatural enantiomer for the adenosine derivatives and the natural enantiomer for 2'-deoxyguanosine. No other tested L-adenosine or L-guanosine analog was a substrate of dCK. Similarly, D- and L-enantiomers of beta-dA, beta-araA, and beta-dG were substrates of human dGK but with different enantioselectivities compared to dCK, especially concerning beta-dA. The present results indicate that human dCK and dGK have similar properties including substrate properties, relaxed enantioselectivities, and possibly catalytic cycles. (C) Societe francaise de biochimie et biologie moleculaire/Editions scientifiques et medicales Elsevier SAS.
引用
收藏
页码:1041 / 1047
页数:7
相关论文
共 47 条
[1]   MAMMALIAN DEOXYRIBONUCLEOSIDE KINASES [J].
ARNER, ESJ ;
ERIKSSON, S .
PHARMACOLOGY & THERAPEUTICS, 1995, 67 (02) :155-186
[2]   Metabolism in human cells of the D and L enantiomers of the carbocyclic analog of 2′-deoxyguanosine:: Substrate activity with deoxycytidine kinase, mitochondrial deoxyguanosine kinase, and 5′-nucleotidase [J].
Bennett, LL ;
Allan, PW ;
Arnett, G ;
Shealy, YF ;
Shewach, DS ;
Mason, WS ;
Fourel, I ;
Parker, WB .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (05) :1045-1051
[3]   Anti-human immunodeficiency and anti-hepatitis B virus activities of beta-L-2',3'-dideoxy purine nucleosides [J].
Bolon, PJ ;
Wang, PY ;
Chu, CK ;
Gosselin, G ;
Boudou, V ;
Pierra, C ;
Mathe, C ;
Imbach, JL ;
Faraj, A ;
Alaoui, MA ;
Sommadossi, JP ;
Pai, SB ;
Zhu, YL ;
Lin, JS ;
Cheng, YC ;
Schinazi, RF .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (14) :1657-1662
[4]  
BOUDOU V, 1997, THESIS U MONTPELLIER
[5]   CRYSTAL-STRUCTURES OF THE THYMIDINE KINASE FROM HERPES-SIMPLEX VIRUS TYPE-I IN COMPLEX WITH DEOXYTHYMIDINE AND GANCICLOVIR [J].
BROWN, DG ;
VISSE, R ;
SANDHU, G ;
DAVIES, A ;
RIZKALLAH, PJ ;
MELITZ, C ;
SUMMERS, WC ;
SANDERSON, MR .
NATURE STRUCTURAL BIOLOGY, 1995, 2 (10) :876-881
[6]  
CHANG CN, 1992, J BIOL CHEM, V267, P22414
[7]  
CHANG CN, 1992, J BIOL CHEM, V267, P13938
[8]   QUANTITATIVE-ANALYSES OF BIOCHEMICAL KINETIC RESOLUTIONS OF ENANTIOMERS [J].
CHEN, CS ;
FUJIMOTO, Y ;
GIRDAUKAS, G ;
SIH, CJ .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1982, 104 (25) :7294-7299
[9]   CLONING AND EXPRESSION OF HUMAN DEOXYCYTIDINE KINASE CDNA [J].
CHOTTINER, EG ;
SHEWACH, DS ;
DATTA, NS ;
ASHCRAFT, E ;
GRIBBIN, D ;
GINSBURG, D ;
FOX, IH ;
MITCHELL, BS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (04) :1531-1535
[10]   Metabolism of 2′,3′-dideoxy-2′,3′-didehydro-β-L(-)-5-flurocytidine and its activity in combination with clinically approved anti-human immunodeficiency virus β-D(+) nucleoside analogs in vitro [J].
Dutschman, GE ;
Bridges, EG ;
Liu, SH ;
Gullen, E ;
Guo, X ;
Kukhanova, M ;
Cheng, YC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (07) :1799-1804